NCT06481163View on ClinicalTrials.gov

Telacebec (T) Treatment in Adults With Buruli Ulcer (BU).

PHASE2RecruitingINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

July 9, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions

Buruli Ulcer

Interventions

DRUG

Telacebec

The test product will be supplied as Telacebec 100mg tablets.

Trial Locations (2)

3220

RECRUITING

Barwon Health, Geelong

Unknown

RECRUITING

Royal Melbourne Hospital, Melbourne

Sponsors

Lead Sponsor

All Listed Sponsors

collaborator

Global Alliance for TB Drug Development

OTHER

lead

Barwon Health

OTHER_GOV